BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹335 Cr | ₹320 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr |
What is the latest Total Liabilities ratio of BAL PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹335 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹311 Cr |
| Mar2022 | ₹261 Cr |
| Mar2021 | ₹240 Cr |
How is Total Liabilities of BAL PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹335 Cr | 4.83 | |
| Mar2024 | ₹320 Cr | 2.84 | |
| Mar2023 | ₹311 Cr | 19.37 | |
| Mar2022 | ₹261 Cr | 8.52 | |
| Mar2021 | ₹240 Cr | - | |
Compare Total Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹101.8 Cr | -4.4% | -16% | -27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.4% |
-16% |
-27.1% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses